Olive and ginkgo extracts as potential cataract therapy with differential inhibitory activity on aldose reductase

Diaaeldin Mohamed Abdelkawi Elimam, Ahmed Salah Uddin Ibrahim, Gregory Ing Liou, Farid Abd Elrehim Abd Elaziz Badria

Research output: Contribution to journalArticle

Abstract

Aldose reductase (AR) has been the leading target in the treatment of diabetic cataract. Although numerous synthetic AR inhibitors (ARI) have been identified, their adverse side effects currently preclude their use. Olive leaf extract (OLE) as well as ginkgo leaf extract (GLE) are natural supplements that have wide therapeutic indices and a plethora of salutary effects during diabetes that so far untested on sugar cataract progression. As such, the present study sought to evaluate the AR-inhibiting properties of OLE and GLE using the isolated enzyme from rabbit lens. Biochemical analyses revealed that both OLE and GLE inhibited rabbit lens AR activity in a concentration-dependent manner with half maximal inhibitory concentration (IC50) 65 µg/mL and 72.5 µg/mL, respectively. Interestingly, the results of kinetic studies exhibited a differential pattern of inhibition by these two extracts. While an non-competitive inhibition of AR was promoted by OLE recognized by significant decrease in the apparent maximum velocity (Vmax) (0.12 ± 0.009677 µM/min versus 0.278 ± 0.0013677 µM/min) without significant change in Michaelis constant (Km), the GLE showed a competitive pattern of inhibition characterized by significant increase in apparent Km (4.4 ± 0.0068 µM), without change in Vmax value. It would appear that these classes of natural extracts represent effective and safe therapeutic options that hold the great promise for treatment not only diabetic cataract, but also other ocular diseases characterized by uncontrolled AR activity.

Original languageEnglish (US)
Pages (from-to)41-46
Number of pages6
Journaldrug discoveries & therapeutics
Volume11
Issue number1
DOIs
StatePublished - Mar 22 2017
Externally publishedYes

Fingerprint

Ginkgo biloba
Aldehyde Reductase
Olea
Cataract
Lenses
Therapeutics
Rabbits
Eye Diseases
Inhibitory Concentration 50
Enzymes

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this

Olive and ginkgo extracts as potential cataract therapy with differential inhibitory activity on aldose reductase. / Elimam, Diaaeldin Mohamed Abdelkawi; Ibrahim, Ahmed Salah Uddin; Liou, Gregory Ing; Badria, Farid Abd Elrehim Abd Elaziz.

In: drug discoveries & therapeutics, Vol. 11, No. 1, 22.03.2017, p. 41-46.

Research output: Contribution to journalArticle

Elimam, Diaaeldin Mohamed Abdelkawi ; Ibrahim, Ahmed Salah Uddin ; Liou, Gregory Ing ; Badria, Farid Abd Elrehim Abd Elaziz. / Olive and ginkgo extracts as potential cataract therapy with differential inhibitory activity on aldose reductase. In: drug discoveries & therapeutics. 2017 ; Vol. 11, No. 1. pp. 41-46.
@article{9923e6bddf394518bf539075605be48b,
title = "Olive and ginkgo extracts as potential cataract therapy with differential inhibitory activity on aldose reductase",
abstract = "Aldose reductase (AR) has been the leading target in the treatment of diabetic cataract. Although numerous synthetic AR inhibitors (ARI) have been identified, their adverse side effects currently preclude their use. Olive leaf extract (OLE) as well as ginkgo leaf extract (GLE) are natural supplements that have wide therapeutic indices and a plethora of salutary effects during diabetes that so far untested on sugar cataract progression. As such, the present study sought to evaluate the AR-inhibiting properties of OLE and GLE using the isolated enzyme from rabbit lens. Biochemical analyses revealed that both OLE and GLE inhibited rabbit lens AR activity in a concentration-dependent manner with half maximal inhibitory concentration (IC50) 65 µg/mL and 72.5 µg/mL, respectively. Interestingly, the results of kinetic studies exhibited a differential pattern of inhibition by these two extracts. While an non-competitive inhibition of AR was promoted by OLE recognized by significant decrease in the apparent maximum velocity (Vmax) (0.12 ± 0.009677 µM/min versus 0.278 ± 0.0013677 µM/min) without significant change in Michaelis constant (Km), the GLE showed a competitive pattern of inhibition characterized by significant increase in apparent Km (4.4 ± 0.0068 µM), without change in Vmax value. It would appear that these classes of natural extracts represent effective and safe therapeutic options that hold the great promise for treatment not only diabetic cataract, but also other ocular diseases characterized by uncontrolled AR activity.",
author = "Elimam, {Diaaeldin Mohamed Abdelkawi} and Ibrahim, {Ahmed Salah Uddin} and Liou, {Gregory Ing} and Badria, {Farid Abd Elrehim Abd Elaziz}",
year = "2017",
month = "3",
day = "22",
doi = "10.5582/ddt.2016.01071",
language = "English (US)",
volume = "11",
pages = "41--46",
journal = "Drug Discoveries and Therapeutics",
issn = "1881-7831",
publisher = "International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.)",
number = "1",

}

TY - JOUR

T1 - Olive and ginkgo extracts as potential cataract therapy with differential inhibitory activity on aldose reductase

AU - Elimam, Diaaeldin Mohamed Abdelkawi

AU - Ibrahim, Ahmed Salah Uddin

AU - Liou, Gregory Ing

AU - Badria, Farid Abd Elrehim Abd Elaziz

PY - 2017/3/22

Y1 - 2017/3/22

N2 - Aldose reductase (AR) has been the leading target in the treatment of diabetic cataract. Although numerous synthetic AR inhibitors (ARI) have been identified, their adverse side effects currently preclude their use. Olive leaf extract (OLE) as well as ginkgo leaf extract (GLE) are natural supplements that have wide therapeutic indices and a plethora of salutary effects during diabetes that so far untested on sugar cataract progression. As such, the present study sought to evaluate the AR-inhibiting properties of OLE and GLE using the isolated enzyme from rabbit lens. Biochemical analyses revealed that both OLE and GLE inhibited rabbit lens AR activity in a concentration-dependent manner with half maximal inhibitory concentration (IC50) 65 µg/mL and 72.5 µg/mL, respectively. Interestingly, the results of kinetic studies exhibited a differential pattern of inhibition by these two extracts. While an non-competitive inhibition of AR was promoted by OLE recognized by significant decrease in the apparent maximum velocity (Vmax) (0.12 ± 0.009677 µM/min versus 0.278 ± 0.0013677 µM/min) without significant change in Michaelis constant (Km), the GLE showed a competitive pattern of inhibition characterized by significant increase in apparent Km (4.4 ± 0.0068 µM), without change in Vmax value. It would appear that these classes of natural extracts represent effective and safe therapeutic options that hold the great promise for treatment not only diabetic cataract, but also other ocular diseases characterized by uncontrolled AR activity.

AB - Aldose reductase (AR) has been the leading target in the treatment of diabetic cataract. Although numerous synthetic AR inhibitors (ARI) have been identified, their adverse side effects currently preclude their use. Olive leaf extract (OLE) as well as ginkgo leaf extract (GLE) are natural supplements that have wide therapeutic indices and a plethora of salutary effects during diabetes that so far untested on sugar cataract progression. As such, the present study sought to evaluate the AR-inhibiting properties of OLE and GLE using the isolated enzyme from rabbit lens. Biochemical analyses revealed that both OLE and GLE inhibited rabbit lens AR activity in a concentration-dependent manner with half maximal inhibitory concentration (IC50) 65 µg/mL and 72.5 µg/mL, respectively. Interestingly, the results of kinetic studies exhibited a differential pattern of inhibition by these two extracts. While an non-competitive inhibition of AR was promoted by OLE recognized by significant decrease in the apparent maximum velocity (Vmax) (0.12 ± 0.009677 µM/min versus 0.278 ± 0.0013677 µM/min) without significant change in Michaelis constant (Km), the GLE showed a competitive pattern of inhibition characterized by significant increase in apparent Km (4.4 ± 0.0068 µM), without change in Vmax value. It would appear that these classes of natural extracts represent effective and safe therapeutic options that hold the great promise for treatment not only diabetic cataract, but also other ocular diseases characterized by uncontrolled AR activity.

UR - http://www.scopus.com/inward/record.url?scp=85021855871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021855871&partnerID=8YFLogxK

U2 - 10.5582/ddt.2016.01071

DO - 10.5582/ddt.2016.01071

M3 - Article

C2 - 28123157

VL - 11

SP - 41

EP - 46

JO - Drug Discoveries and Therapeutics

JF - Drug Discoveries and Therapeutics

SN - 1881-7831

IS - 1

ER -